Silence Therapeutics (SLN) Change in Account Payables (2020 - 2024)
Silence Therapeutics recorded quarterly Change in Account Payables of -$862735.3 in Q3 2024, down 114.74% quarter-over-quarter from $5.9 million in Q2 2024, and down 824.57% year-over-year from $119068.4 in Q4 2023.
Silence Therapeutics' Change in Account Payables history runs 5 years deep, the most recent figure standing at -$862735.3 for Q3 2024.
- In Q3 2024, Change in Account Payables fell 824.57% year-over-year to -$862735.3; the TTM figure through Sep 2024 stood at $3.2 million (up 189.91% YoY), while the FY2023 annual figure was $54610.7, down 96.95% from the prior year.
- Change in Account Payables came in at -$862735.3 for Q3 2024 at Silence Therapeutics, down from $5.9 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $5.9 million in Q2 2024 to a low of -$4.2 million in Q1 2022.
- A 5-year average of $688904.8 and a median of $939552.0 in 2023 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 481.42% in 2024 and fell as far as 824.57% in 2024.
- Silence Therapeutics' Change in Account Payables stood at $2.9 million in 2020, then tumbled by 37.27% to $1.8 million in 2021, then tumbled by 247.3% to -$2.7 million in 2022, then soared by 134.77% to $939552.0 in 2023, then plunged by 191.82% to -$862735.3 in 2024.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$862735.3, $5.9 million, and -$2.7 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -862,735.31 |
| Sep 30, 2024 | -862,735.31 |
| Jun 30, 2024 | 5.85 Mn |
| Jun 30, 2024 | 5.85 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | 939,551.98 |
| Dec 31, 2023 | 939,551.98 |
| Sep 30, 2023 | 119,068.37 |
| Sep 30, 2023 | 119,068.37 |
| Jun 30, 2023 | -1.53 Mn |
| Jun 30, 2023 | -1.53 Mn |
| Mar 31, 2023 | 509,298.49 |
| Mar 31, 2023 | 509,298.49 |
| Dec 31, 2022 | -2.70 Mn |
| Dec 31, 2022 | -2.70 Mn |
| Sep 30, 2022 | 3.56 Mn |
| Sep 30, 2022 | 3.56 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Mar 31, 2022 | -4.16 Mn |
| Mar 31, 2022 | -4.16 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 1.88 Mn |
| Sep 30, 2021 | 1.88 Mn |
| Jun 30, 2021 | 1.52 Mn |
| Jun 30, 2021 | 1.52 Mn |
| Mar 31, 2021 | -1.94 Mn |
| Mar 31, 2021 | -1.94 Mn |
| Dec 31, 2020 | 2.92 Mn |
| Dec 31, 2020 | 2.92 Mn |
| Sep 30, 2020 | 1.63 Mn |
| Sep 30, 2020 | 1.63 Mn |